Title: Research Communications of the 24th ECVIM-CA Congress Document date: 2015_1_10
ID: r59usk02_189
Snippet: The study was financially supported by the Swedish Juvenile Diabetes Foundation, the Fredrik and Ingrid Thuring Foundation, the Magnus Bergvall Foundation, the Lars Hierta Memorial Foundation, and the Foundation for Research, Agria Insurance Company. Feline acromegaly is an increasingly recognised endocrinopathy among diabetic cats, caused by chronic excessive growth hormone secretion by a functional somatotrophinoma in the pars distalis of the a.....
Document: The study was financially supported by the Swedish Juvenile Diabetes Foundation, the Fredrik and Ingrid Thuring Foundation, the Magnus Bergvall Foundation, the Lars Hierta Memorial Foundation, and the Foundation for Research, Agria Insurance Company. Feline acromegaly is an increasingly recognised endocrinopathy among diabetic cats, caused by chronic excessive growth hormone secretion by a functional somatotrophinoma in the pars distalis of the anterior pituitary gland. The majority of human somatotrophinomas are sporadic, however up to 20% of familial isolated pituitary adenomas are caused by germline mutations of the aryl-hydrocarbon-receptor interacting protein (AIP). Feline acromegaly has phenotypic and biochemical similarities to human familial acromegaly with AIP mutations, such as male predominance, somatotroph macroadenoma and resistance to octreotide therapy.
Search related documents:
Co phrase search for related documents- growth hormone and hydrocarbon receptor: 1
- growth hormone and male predominance: 1
- growth hormone secretion and pituitary adenoma: 1
- growth hormone secretion and pituitary gland: 1
- human somatotrophinomas majority and hydrocarbon receptor: 1
- human somatotrophinomas majority and male predominance: 1
- human somatotrophinomas majority and octreotide therapy: 1
- human somatotrophinomas majority and pituitary gland: 1
- human somatotrophinomas majority and resistance somatotroph macroadenoma male predominance: 1
- hydrocarbon receptor and male predominance: 1
- hydrocarbon receptor and octreotide therapy: 1
- hydrocarbon receptor and pituitary gland: 1
- hydrocarbon receptor and resistance somatotroph macroadenoma male predominance: 1
- male predominance and octreotide therapy: 1
- male predominance and pituitary gland: 1
- male predominance and resistance somatotroph macroadenoma male predominance: 1
- octreotide therapy and pituitary gland: 1
- octreotide therapy and resistance somatotroph macroadenoma male predominance: 1
- pituitary gland and resistance somatotroph macroadenoma male predominance: 1
Co phrase search for related documents, hyperlinks ordered by date